Advertisement

Editor Profile

Robert Dreicer, MD, MS, FACP

Associate Editor

About the NEJM Watch Oncology and Hematology Board

Dr. Dreicer is the Chair of the Department of Solid Tumor Oncology at Cleveland Clinic in Cleveland, Ohio. He received his Medical Degree and Master of Science from the University of Texas, Houston. He completed internal medicine residency training at Indiana University and a medical oncology fellowship at the University of Wisconsin. He is a fellow of the American College of Physicians. Dr. Dreicer is an academic clinical investigator in the area of urologic oncology. He chairs the bladder subcommittee in the Eastern Cooperative Oncology Group and is a member of the American Board of Internal Medicine, Medical Oncology Subspecialty Board. Dr. Dreicer has been writing for NEJM Journal Watch Oncology and Hematology since 2006.

Disclosures

Consultant / Advisory board

Dendreon; Eli-Lilly; Endo Pharmaceuticals; Ferring; Janssen; Millennium; Novartis

Speaker's bureau

Janssen

Grant / Research support

Progenics

Editorial boards

Urology

Leadership positions in professional societies

National Cancer Institute (Co-Chair, GU Oncology Steering Committee)

Summaries by Robert Dreicer

Pages